- Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
-
Kim J, Lee SH, Kim HS, Choi K, Jeong SW, Kim SG, Jang JY, Kim YS, Kim BS
- KMID: 2380789
- Gut Liver.
- 2015 Jan;9(1):103-108.
- doi: 10.5009/gnl14018
BACKGROUND/AIMS: To investigate the association between the baseline profiles and dynamics of hepatitis B virus (HBV) DNA polymerase gene mutations and the long-term virological response of lamivudine (LAM)-adefovir (ADV) combination... -
- CITED
-
- Close
- SHARE
-
- Close
- Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment
-
Jung JK, Lee CH, Kim EY, Jung JT, Choi JH, Han JM, Jin MI, Cho JY, Kim BS, Shin IH
- KMID: 1776827
- Korean J Hepatol.
- 2007 Dec;13(4):513-520.
- doi: 10.3350/kjhep.2007.13.4.513
BACKGROUND AND AIMS: Lamivudine is an effective, safe therapeutic agent for the treatment of chronic hepatitis B. The aim of this study was to investigate whether early suppression of... -
- CITED
-
- Close
- SHARE
-
- Close
